"This board makes me lough
I thought this is a stock massage board, didn't knew that it is a platform for writing mini scientific opinion paper for the scientist who never have the ability of publishing in real journals. What you know about mature immature DC NK cell T-reg TH cell activation sits - how about going ahead and publishing them in real journal favoring or disfavoring the results of what NWBO doing and limit here discussion on the prospect of this stock in terms of making money- instead of making it a jungle. you guys making everyone sick here you know."
-----------------------------------------------------------------
Perhaps you are unaware of how smallcap biotechs trade. Predicting efficacy is necessary in predicting shareprice, particularly if a phase 3 is close to finishing. This is known as a binary event when there is no fallback product... though not exactly the case here.
Sometimes if a product gains FDA or European approval, a stock can jump 3X, or 10X, or 30X, or even 40X if the price is severely depressed at the time due to low expectations of approval and or a general suspicion, however unfounded, that major business issues are improper internal, and such concerns are alleviated about the same time that efficacy is validated or the product gains approval. Same would apply to depression of share-price due to manipulation with the optics cover of the business or efficacy problems because if such problems clearly disappear, and the share-price does not recover in a natural way, it becomes clear that manipulation has been the cause and in the current Moonshot environment would likely lead to a real federal inquiry outside of the SEC dredging up all kinds of sludge and slugs. bndvrndsayahbad.
